Introduction
Concentrations of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in plasma of fetuses follow a characteristic pattern of change throughout pregnancy in many species. Concen¬ trations of LH and FSH in plasma of sheep and human fetuses are higher at mid-gestation than before birth (Foster et al., 1972; Sklar et al., 1981; Mulchahey et ai, 1987) . Furthermore, there is a difference between the sexes in fetal gonadotrophins; concentrations of circulating LH and FSH are lower in male than in female fetuses (Kaplan et ai, 1976; Sklar et al., 1981) . This difference has been attributed to the negative feedback effects of high circulating testosterone concentrations seen in male fetuses (Ellinwood et al., 1982; Matwijiw & Faiman, 1989) . LH is secreted in a pulsatile fashion in sheep fetuses (Clark et al., 1984; Matwijiw & Faiman, 1989) , pig fetuses (Ponzilius et ai, 1986) and rhesus monkey fetuses (Jaffe et al., 1988) . This pulsatile mode of LH secretion depends on luteinizing-hormone-releasing hormone (LHRH) since administration of an LHRH receptor antagonist to immature sheep fetuses blocks episodic LH secretion (Matwijiw & Faiman, 1987) .
A physiological role for these high fetal gonadotrophin concentrations has been implied, largely on the basis of data obtained from anencephalic human fetuses. In this situation, male fetuses usually have hypoplastic male external genitalia, undescended testes and a reduced number of Leydig cells (Kaplan et al., 1976) . In the female fetus the stage of intense transformation of oogonia into primordial follicles coincides with high concentrations of FSH in the fetus (Grumbach & Kaplan, 1973) . The female anencephalic fetus has small hypoplastic ovaries and reduced numbers of primordial and primary follicles (Ross, 1974; Kaplan et al., 1976) . Hypophysectomy of rhesus monkey fetuses decreases the weight of the fetal testis as well as the percentage of Leydig cells and spermatogonia. In female fetuses hypophysectomy decreases ovarian weight and causes an increase in germ cell atresia (Gulyas et al., 1977a, b 
Pituitary extraction
Frozen fetal pituitaries (including the anterior, posterior and intermediate lobes) were homogenized using a glass homogenizer in 1 ml 50 mmol Na2C03 1" temperature, a 20 µ aliquot was removed for protein determination using a BioRad assay kit. The remaining homogenate was centrifuged at 10 000 g for 30 min and the supernatant was stored at -15°C until assayed.
Radioimmunoassays
Concentrations of LH were measured in 50 µ aliquots of plasma and diluted pituitary extracts by radioimmunoassay using the method of McNeilly et al. (1986) . The lower limit of detection was improved by halving the quantities of reagents added to each tube and within this study was 005 ng ml" ' using NIH-LH-S23 as a reference standard. The mean inter-and intra-assay coefficients of variation were 12-5% and 8%, respectively, for three quality control plasma pools included in each assay. Concentrations of FSH were also measured using a similar modified version of the radioimmunoassay method of McNeilly et al. (1976) . The lower limit of sensitivity was 0-4 ng ml-1 using anti-oFSHl and RP1 standard and the inter-and intra-assay coefficients of variation were 11% and 9%, respectively. Influence of buserelin on gonadal development There were no significant differences in the weights of the fetal pituitaries, ovaries or testes (calculated as a percentage of body weight) between control and buserelin-treated fetuses (data not shown). On histological examination, the testes of control and agonist-treated fetuses appeared morphologically similar (Fig. 3) . Seminiferous tubules were similar in size and contained many spermatogonia occupying a predominantly basal orientation. The interstitial spaces were large and contained numerous Leydig cells. The number of Leydig cells and their degree of differentiation were unchanged by agonist treatment. The fetal ovaries were characterized by a cortical layer of primordial follicles of varying diameter. The number, size and distribution of this follicular layer was not influenced by agonist treatment (Fig. 3) .
Statistical analysis

Discussion
In this study we (Dubois & Mauleon, 1969) and electron microscopy (Alexander et al., 1973) by about day 50 of gestation. However, there (Matwijiw & Faiman, 1989) . However, at mid-gestation (i.e. about day 70) fetal LH and FSH concentrations are higher in female than in male fetuses (Sklar et ai, 1981) , a difference that is thought to result from high testosterone concentrations in male fetuses (Matwijiw & Faiman, 1989) . Clearly this sex difference is not maintained throughout pregnancy, probably as a result of increasing circulating steroids of placental origin that have the potential to exert negative feedback effects on the hypothalamo-pituitary-gonadal axis (Gluckman et al., 1983 ).
The finding that suppression of fetal gonadotrophin secretion between day 70 and day 111 of gestation had no effect on the morphological development of the fetal gonads was surprising in view of data showing that removal of the fetal pituitary results in abnormal development of the fetal gonads (Liggins & Kennedy, 1968; VanVorstenbosch, 1984 (Liggins & Kennedy, 1968; Ross, 1974; Gulyas et al., 1977a, b 
